Reviv3 amends voting agreement to exempt private placements and offerings up to $50M from issuance restrictions

Axil Brands, Inc.

Amendment effective Nov 7, 2022 modifies definition of "New Securities" in the Voting Agreement.
New exemptions include private placements exempt from registration and securities offerings up to $50M per offering.
Approval from Intrepid and Axil no longer required for such issuances as long as Axil holds majority of Preferred Shares.
Jeff Toghraie, Reviv3 CEO, also serves as Managing Director of Intrepid, a party to the agreement.
The amendment is effective immediately and governed by Delaware law.

Key facts

Extracted from this filing and checked against the source text.

Material Agreements SEC 8-K Item 1.01/1.02 confidence 0.95

Axil Brands, Inc. amended Voting Agreement Amendment with Intrepid Global Advisors, Inc. valued at Amendment to Voting Agreement to revise securities exempted from term "New Securities" (effective 2022-11-07).

Action: amendment
Counterparty: Intrepid Global Advisors, Inc.
Value: Amendment to Voting Agreement to revise securities exempted from term "New Securities"
Effective: 2022-11-07

Exact text from the filing

Effective as of November 7, 2022, Reviv3 Procare Company (the “Company”) entered into an amendment (the “Amendment”) to the Voting Agreement, effective as of June 16, 2022 (the “Voting Agreement”), by and among the Company, Intrepid Global Advisors, Inc. (“Intrepid), and Axil & Associated Brands Corp. (“Axil”), to revise the securities exempted from the term “New Securities,” as defined in the Voting Agreement.

View on SEC.gov

Browse all material agreements →

Axil Brands, Inc. filing history →

Source: SEC EDGAR

accession 0001520138-22-000504

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.